Patient-Focused Drug Development Grants May Be Program’s ‘Most Significant’ Accomplishment Since 2019
Executive Summary
US FDA has issued five grants for development of standard core clinical outcome assessments and related endpoints that can be used across disease areas and may produce more reliable data for regulatory decision-making.